nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—CYP1A2—Betaxolol—glaucoma	0.113	0.264	CbGbCtD
Agomelatine—CYP2C9—Diclofenamide—glaucoma	0.09	0.209	CbGbCtD
Agomelatine—CYP2C9—Dorzolamide—glaucoma	0.0869	0.202	CbGbCtD
Agomelatine—CYP2C9—Methazolamide—glaucoma	0.0774	0.18	CbGbCtD
Agomelatine—CYP1A2—Clonidine—glaucoma	0.0621	0.145	CbGbCtD
Agomelatine—Melatonin—CYP1B1—glaucoma	0.00225	0.391	CrCbGaD
Agomelatine—Nabumetone—PTGS2—glaucoma	0.00191	0.331	CrCbGaD
Agomelatine—Dizziness—Carbachol—glaucoma	0.000995	0.00246	CcSEcCtD
Agomelatine—Insomnia—Apraclonidine—glaucoma	0.000994	0.00245	CcSEcCtD
Agomelatine—Vertigo—Dorzolamide—glaucoma	0.000992	0.00245	CcSEcCtD
Agomelatine—Vertigo—Travoprost—glaucoma	0.000987	0.00244	CcSEcCtD
Agomelatine—Paraesthesia—Apraclonidine—glaucoma	0.000987	0.00243	CcSEcCtD
Agomelatine—Vision blurred—Pilocarpine—glaucoma	0.000983	0.00243	CcSEcCtD
Agomelatine—Headache—Carteolol—glaucoma	0.000983	0.00242	CcSEcCtD
Agomelatine—Anxiety—Brimonidine—glaucoma	0.000981	0.00242	CcSEcCtD
Agomelatine—Vomiting—Diclofenamide—glaucoma	0.00098	0.00242	CcSEcCtD
Agomelatine—Dizziness—Levobunolol—glaucoma	0.00098	0.00242	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000977	0.00241	CcSEcCtD
Agomelatine—Tremor—Pilocarpine—glaucoma	0.000977	0.00241	CcSEcCtD
Agomelatine—Somnolence—Apraclonidine—glaucoma	0.000977	0.00241	CcSEcCtD
Agomelatine—Vertigo—Brinzolamide—glaucoma	0.000975	0.00241	CcSEcCtD
Agomelatine—Pruritus—Latanoprost—glaucoma	0.000972	0.0024	CcSEcCtD
Agomelatine—Diarrhoea—Methazolamide—glaucoma	0.000971	0.0024	CcSEcCtD
Agomelatine—Headache—Diclofenamide—glaucoma	0.000966	0.00238	CcSEcCtD
Agomelatine—Insomnia—Bimatoprost—glaucoma	0.000963	0.00238	CcSEcCtD
Agomelatine—Dry mouth—Brimonidine—glaucoma	0.000962	0.00237	CcSEcCtD
Agomelatine—Agitation—Pilocarpine—glaucoma	0.000958	0.00236	CcSEcCtD
Agomelatine—Vomiting—Carbachol—glaucoma	0.000957	0.00236	CcSEcCtD
Agomelatine—Hepatitis—Clonidine—glaucoma	0.000957	0.00236	CcSEcCtD
Agomelatine—Hallucination—Clonidine—glaucoma	0.000952	0.00235	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000949	0.00234	CcSEcCtD
Agomelatine—Fatigue—Apraclonidine—glaucoma	0.000947	0.00234	CcSEcCtD
Agomelatine—Weight increased—Betaxolol—glaucoma	0.000947	0.00234	CcSEcCtD
Agomelatine—Somnolence—Bimatoprost—glaucoma	0.000947	0.00234	CcSEcCtD
Agomelatine—Headache—Carbachol—glaucoma	0.000943	0.00233	CcSEcCtD
Agomelatine—Weight decreased—Betaxolol—glaucoma	0.000941	0.00232	CcSEcCtD
Agomelatine—Constipation—Apraclonidine—glaucoma	0.00094	0.00232	CcSEcCtD
Agomelatine—Dyspepsia—Bimatoprost—glaucoma	0.000938	0.00231	CcSEcCtD
Agomelatine—Infection—Brimonidine—glaucoma	0.000937	0.00231	CcSEcCtD
Agomelatine—Anxiety—Dorzolamide—glaucoma	0.000936	0.00231	CcSEcCtD
Agomelatine—Anxiety—Travoprost—glaucoma	0.000932	0.0023	CcSEcCtD
Agomelatine—Nausea—Carteolol—glaucoma	0.000932	0.0023	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000929	0.00229	CcSEcCtD
Agomelatine—Headache—Levobunolol—glaucoma	0.000928	0.00229	CcSEcCtD
Agomelatine—Infestation NOS—Betaxolol—glaucoma	0.000928	0.00229	CcSEcCtD
Agomelatine—Infestation—Betaxolol—glaucoma	0.000928	0.00229	CcSEcCtD
Agomelatine—Depression—Betaxolol—glaucoma	0.000925	0.00228	CcSEcCtD
Agomelatine—Nervous system disorder—Brimonidine—glaucoma	0.000925	0.00228	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00092	0.00227	CcSEcCtD
Agomelatine—Dry mouth—Dorzolamide—glaucoma	0.000919	0.00227	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000917	0.00226	CcSEcCtD
Agomelatine—Skin disorder—Brimonidine—glaucoma	0.000916	0.00226	CcSEcCtD
Agomelatine—Nausea—Diclofenamide—glaucoma	0.000916	0.00226	CcSEcCtD
Agomelatine—Dry mouth—Travoprost—glaucoma	0.000915	0.00226	CcSEcCtD
Agomelatine—Dizziness—Latanoprost—glaucoma	0.000909	0.00224	CcSEcCtD
Agomelatine—Dry mouth—Brinzolamide—glaucoma	0.000903	0.00223	CcSEcCtD
Agomelatine—Vomiting—Methazolamide—glaucoma	0.000903	0.00223	CcSEcCtD
Agomelatine—Gastrointestinal pain—Apraclonidine—glaucoma	0.000898	0.00222	CcSEcCtD
Agomelatine—Eye disorder—Clonidine—glaucoma	0.000894	0.00221	CcSEcCtD
Agomelatine—Nausea—Carbachol—glaucoma	0.000894	0.00221	CcSEcCtD
Agomelatine—Tinnitus—Clonidine—glaucoma	0.000892	0.0022	CcSEcCtD
Agomelatine—Infection—Travoprost—glaucoma	0.000891	0.0022	CcSEcCtD
Agomelatine—Headache—Methazolamide—glaucoma	0.000889	0.00219	CcSEcCtD
Agomelatine—Anxiety—Pilocarpine—glaucoma	0.000885	0.00218	CcSEcCtD
Agomelatine—Naproxen—PTGS2—glaucoma	0.000883	0.153	CrCbGaD
Agomelatine—Paraesthesia—Acetazolamide—glaucoma	0.000882	0.00218	CcSEcCtD
Agomelatine—Nausea—Levobunolol—glaucoma	0.00088	0.00217	CcSEcCtD
Agomelatine—Infection—Brinzolamide—glaucoma	0.00088	0.00217	CcSEcCtD
Agomelatine—Nervous system disorder—Travoprost—glaucoma	0.00088	0.00217	CcSEcCtD
Agomelatine—Nasopharyngitis—Timolol—glaucoma	0.00088	0.00217	CcSEcCtD
Agomelatine—Somnolence—Acetazolamide—glaucoma	0.000874	0.00216	CcSEcCtD
Agomelatine—Skin disorder—Travoprost—glaucoma	0.000871	0.00215	CcSEcCtD
Agomelatine—Hyperhidrosis—Dorzolamide—glaucoma	0.000871	0.00215	CcSEcCtD
Agomelatine—Abdominal pain—Apraclonidine—glaucoma	0.000869	0.00214	CcSEcCtD
Agomelatine—Nervous system disorder—Brinzolamide—glaucoma	0.000868	0.00214	CcSEcCtD
Agomelatine—Dyspepsia—Acetazolamide—glaucoma	0.000865	0.00213	CcSEcCtD
Agomelatine—Headache—Latanoprost—glaucoma	0.000861	0.00212	CcSEcCtD
Agomelatine—Skin disorder—Brinzolamide—glaucoma	0.00086	0.00212	CcSEcCtD
Agomelatine—Insomnia—Brimonidine—glaucoma	0.000853	0.0021	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000848	0.00209	CcSEcCtD
Agomelatine—Fatigue—Acetazolamide—glaucoma	0.000847	0.00209	CcSEcCtD
Agomelatine—Paraesthesia—Brimonidine—glaucoma	0.000847	0.00209	CcSEcCtD
Agomelatine—Infection—Pilocarpine—glaucoma	0.000846	0.00209	CcSEcCtD
Agomelatine—Nausea—Methazolamide—glaucoma	0.000843	0.00208	CcSEcCtD
Agomelatine—Somnolence—Brimonidine—glaucoma	0.000839	0.00207	CcSEcCtD
Agomelatine—Mental disorder—Clonidine—glaucoma	0.000838	0.00207	CcSEcCtD
Agomelatine—Dyspepsia—Brimonidine—glaucoma	0.00083	0.00205	CcSEcCtD
Agomelatine—Hallucination—Betaxolol—glaucoma	0.000829	0.00204	CcSEcCtD
Agomelatine—Hyperhidrosis—Pilocarpine—glaucoma	0.000823	0.00203	CcSEcCtD
Agomelatine—Insomnia—Dorzolamide—glaucoma	0.000815	0.00201	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000814	0.00201	CcSEcCtD
Agomelatine—Fatigue—Brimonidine—glaucoma	0.000813	0.00201	CcSEcCtD
Agomelatine—Paraesthesia—Dorzolamide—glaucoma	0.000809	0.002	CcSEcCtD
Agomelatine—Insomnia—Brinzolamide—glaucoma	0.000801	0.00198	CcSEcCtD
Agomelatine—Somnolence—Dorzolamide—glaucoma	0.000801	0.00198	CcSEcCtD
Agomelatine—Paraesthesia—Brinzolamide—glaucoma	0.000795	0.00196	CcSEcCtD
Agomelatine—Dyspepsia—Dorzolamide—glaucoma	0.000793	0.00196	CcSEcCtD
Agomelatine—Dyspepsia—Travoprost—glaucoma	0.00079	0.00195	CcSEcCtD
Agomelatine—Asthenia—Apraclonidine—glaucoma	0.000788	0.00194	CcSEcCtD
Agomelatine—Somnolence—Brinzolamide—glaucoma	0.000787	0.00194	CcSEcCtD
Agomelatine—Vision blurred—Clonidine—glaucoma	0.000785	0.00194	CcSEcCtD
Agomelatine—Urticaria—Acetazolamide—glaucoma	0.000781	0.00193	CcSEcCtD
Agomelatine—Tremor—Clonidine—glaucoma	0.00078	0.00193	CcSEcCtD
Agomelatine—Dyspepsia—Brinzolamide—glaucoma	0.00078	0.00192	CcSEcCtD
Agomelatine—Eye disorder—Betaxolol—glaucoma	0.000778	0.00192	CcSEcCtD
Agomelatine—Pruritus—Apraclonidine—glaucoma	0.000777	0.00192	CcSEcCtD
Agomelatine—Fatigue—Dorzolamide—glaucoma	0.000777	0.00192	CcSEcCtD
Agomelatine—Tinnitus—Betaxolol—glaucoma	0.000777	0.00192	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Travoprost—glaucoma	0.000774	0.00191	CcSEcCtD
Agomelatine—Fatigue—Travoprost—glaucoma	0.000773	0.00191	CcSEcCtD
Agomelatine—Insomnia—Pilocarpine—glaucoma	0.00077	0.0019	CcSEcCtD
Agomelatine—Weight decreased—Timolol—glaucoma	0.000769	0.0019	CcSEcCtD
Agomelatine—Constipation—Travoprost—glaucoma	0.000767	0.00189	CcSEcCtD
Agomelatine—Agitation—Clonidine—glaucoma	0.000765	0.00189	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000765	0.00189	CcSEcCtD
Agomelatine—Paraesthesia—Pilocarpine—glaucoma	0.000764	0.00189	CcSEcCtD
Agomelatine—Asthenia—Bimatoprost—glaucoma	0.000764	0.00189	CcSEcCtD
Agomelatine—Fatigue—Brinzolamide—glaucoma	0.000764	0.00188	CcSEcCtD
Agomelatine—Angioedema—Clonidine—glaucoma	0.000761	0.00188	CcSEcCtD
Agomelatine—Somnolence—Pilocarpine—glaucoma	0.000757	0.00187	CcSEcCtD
Agomelatine—Depression—Timolol—glaucoma	0.000756	0.00186	CcSEcCtD
Agomelatine—Pruritus—Bimatoprost—glaucoma	0.000754	0.00186	CcSEcCtD
Agomelatine—Diarrhoea—Apraclonidine—glaucoma	0.000752	0.00185	CcSEcCtD
Agomelatine—Dyspepsia—Pilocarpine—glaucoma	0.000749	0.00185	CcSEcCtD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000746	0.00469	CbGpPWpGaD
Agomelatine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000737	0.00182	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000735	0.00181	CcSEcCtD
Agomelatine—Gastrointestinal pain—Travoprost—glaucoma	0.000733	0.00181	CcSEcCtD
Agomelatine—Mental disorder—Betaxolol—glaucoma	0.00073	0.0018	CcSEcCtD
Agomelatine—Constipation—Pilocarpine—glaucoma	0.000728	0.0018	CcSEcCtD
Agomelatine—Dizziness—Apraclonidine—glaucoma	0.000727	0.00179	CcSEcCtD
Agomelatine—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000723	0.00454	CbGpPWpGaD
Agomelatine—Indomethacin—PTGS2—glaucoma	0.000716	0.124	CrCbGaD
Agomelatine—Urticaria—Dorzolamide—glaucoma	0.000716	0.00177	CcSEcCtD
Agomelatine—Abdominal pain—Dorzolamide—glaucoma	0.000712	0.00176	CcSEcCtD
Agomelatine—Abdominal pain—Travoprost—glaucoma	0.000709	0.00175	CcSEcCtD
Agomelatine—Anxiety—Clonidine—glaucoma	0.000707	0.00174	CcSEcCtD
Agomelatine—Asthenia—Acetazolamide—glaucoma	0.000705	0.00174	CcSEcCtD
Agomelatine—Dizziness—Bimatoprost—glaucoma	0.000704	0.00174	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000704	0.00174	CcSEcCtD
Agomelatine—Urticaria—Brinzolamide—glaucoma	0.000704	0.00174	CcSEcCtD
Agomelatine—HTR2C—G alpha (q) signalling events—PTGFR—glaucoma	0.000701	0.00441	CbGpPWpGaD
Agomelatine—Vomiting—Apraclonidine—glaucoma	0.000699	0.00172	CcSEcCtD
Agomelatine—MTNR1A—Signaling by GPCR—PTGFR—glaucoma	0.000697	0.00438	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—PTGFR—glaucoma	0.000697	0.00438	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.000697	0.00438	CbGpPWpGaD
Agomelatine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000696	0.00172	CcSEcCtD
Agomelatine—Dry mouth—Clonidine—glaucoma	0.000693	0.00171	CcSEcCtD
Agomelatine—Headache—Apraclonidine—glaucoma	0.000688	0.0017	CcSEcCtD
Agomelatine—MTNR1A—GPCR ligand binding—SMO—glaucoma	0.000685	0.0043	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—SMO—glaucoma	0.000685	0.0043	CbGpPWpGaD
Agomelatine—Vision blurred—Betaxolol—glaucoma	0.000683	0.00169	CcSEcCtD
Agomelatine—Tremor—Betaxolol—glaucoma	0.000679	0.00168	CcSEcCtD
Agomelatine—Hallucination—Timolol—glaucoma	0.000677	0.00167	CcSEcCtD
Agomelatine—Asthenia—Brimonidine—glaucoma	0.000677	0.00167	CcSEcCtD
Agomelatine—Infection—Clonidine—glaucoma	0.000675	0.00167	CcSEcCtD
Agomelatine—Abdominal pain—Pilocarpine—glaucoma	0.000673	0.00166	CcSEcCtD
Agomelatine—Diarrhoea—Acetazolamide—glaucoma	0.000672	0.00166	CcSEcCtD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000672	0.00422	CbGpPWpGaD
Agomelatine—Connective tissue disorder—Timolol—glaucoma	0.000669	0.00165	CcSEcCtD
Agomelatine—Pruritus—Brimonidine—glaucoma	0.000667	0.00165	CcSEcCtD
Agomelatine—Headache—Bimatoprost—glaucoma	0.000667	0.00165	CcSEcCtD
Agomelatine—Nervous system disorder—Clonidine—glaucoma	0.000667	0.00164	CcSEcCtD
Agomelatine—Skin disorder—Clonidine—glaucoma	0.00066	0.00163	CcSEcCtD
Agomelatine—MTNR1A—Signaling Pathways—LRP12—glaucoma	0.00066	0.00414	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—LRP12—glaucoma	0.00066	0.00414	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000658	0.00414	CbGpPWpGaD
Agomelatine—Hyperhidrosis—Clonidine—glaucoma	0.000657	0.00162	CcSEcCtD
Agomelatine—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000654	0.00411	CbGpPWpGaD
Agomelatine—Nausea—Apraclonidine—glaucoma	0.000653	0.00161	CcSEcCtD
Agomelatine—Vertigo—Betaxolol—glaucoma	0.000651	0.00161	CcSEcCtD
Agomelatine—MTNR1A—G alpha (i) signalling events—C3—glaucoma	0.000651	0.00409	CbGpPWpGaD
Agomelatine—MTNR1B—G alpha (i) signalling events—C3—glaucoma	0.000651	0.00409	CbGpPWpGaD
Agomelatine—Dizziness—Acetazolamide—glaucoma	0.00065	0.0016	CcSEcCtD
Agomelatine—Asthenia—Dorzolamide—glaucoma	0.000646	0.00159	CcSEcCtD
Agomelatine—Asthenia—Travoprost—glaucoma	0.000644	0.00159	CcSEcCtD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000639	0.00402	CbGpPWpGaD
Agomelatine—Pruritus—Dorzolamide—glaucoma	0.000637	0.00157	CcSEcCtD
Agomelatine—Eye disorder—Timolol—glaucoma	0.000636	0.00157	CcSEcCtD
Agomelatine—Asthenia—Brinzolamide—glaucoma	0.000635	0.00157	CcSEcCtD
Agomelatine—Pruritus—Travoprost—glaucoma	0.000635	0.00157	CcSEcCtD
Agomelatine—Tinnitus—Timolol—glaucoma	0.000634	0.00157	CcSEcCtD
Agomelatine—Nausea—Bimatoprost—glaucoma	0.000633	0.00156	CcSEcCtD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.000627	0.00394	CbGpPWpGaD
Agomelatine—Pruritus—Brinzolamide—glaucoma	0.000627	0.00155	CcSEcCtD
Agomelatine—Vomiting—Acetazolamide—glaucoma	0.000625	0.00154	CcSEcCtD
Agomelatine—Dizziness—Brimonidine—glaucoma	0.000624	0.00154	CcSEcCtD
Agomelatine—Diarrhoea—Dorzolamide—glaucoma	0.000616	0.00152	CcSEcCtD
Agomelatine—Headache—Acetazolamide—glaucoma	0.000616	0.00152	CcSEcCtD
Agomelatine—Anxiety—Betaxolol—glaucoma	0.000615	0.00152	CcSEcCtD
Agomelatine—Insomnia—Clonidine—glaucoma	0.000615	0.00152	CcSEcCtD
Agomelatine—Diarrhoea—Travoprost—glaucoma	0.000614	0.00151	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000613	0.00151	CcSEcCtD
Agomelatine—Asthenia—Pilocarpine—glaucoma	0.000611	0.00151	CcSEcCtD
Agomelatine—Paraesthesia—Clonidine—glaucoma	0.00061	0.00151	CcSEcCtD
Agomelatine—Diarrhoea—Brinzolamide—glaucoma	0.000606	0.0015	CcSEcCtD
Agomelatine—Somnolence—Clonidine—glaucoma	0.000604	0.00149	CcSEcCtD
Agomelatine—Dry mouth—Betaxolol—glaucoma	0.000604	0.00149	CcSEcCtD
Agomelatine—Pruritus—Pilocarpine—glaucoma	0.000602	0.00149	CcSEcCtD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000602	0.00378	CbGpPWpGaD
Agomelatine—Mental disorder—Timolol—glaucoma	0.000596	0.00147	CcSEcCtD
Agomelatine—Dizziness—Dorzolamide—glaucoma	0.000596	0.00147	CcSEcCtD
Agomelatine—Dizziness—Travoprost—glaucoma	0.000593	0.00146	CcSEcCtD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000593	0.00372	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000593	0.00372	CbGpPWpGaD
Agomelatine—Headache—Brimonidine—glaucoma	0.000591	0.00146	CcSEcCtD
Agomelatine—Infection—Betaxolol—glaucoma	0.000588	0.00145	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Clonidine—glaucoma	0.000587	0.00145	CcSEcCtD
Agomelatine—Fatigue—Clonidine—glaucoma	0.000586	0.00145	CcSEcCtD
Agomelatine—Dizziness—Brinzolamide—glaucoma	0.000586	0.00144	CcSEcCtD
Agomelatine—Nausea—Acetazolamide—glaucoma	0.000584	0.00144	CcSEcCtD
Agomelatine—Diarrhoea—Pilocarpine—glaucoma	0.000582	0.00144	CcSEcCtD
Agomelatine—Constipation—Clonidine—glaucoma	0.000581	0.00143	CcSEcCtD
Agomelatine—Nervous system disorder—Betaxolol—glaucoma	0.00058	0.00143	CcSEcCtD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000576	0.00362	CbGpPWpGaD
Agomelatine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000575	0.00361	CbGpPWpGaD
Agomelatine—Skin disorder—Betaxolol—glaucoma	0.000575	0.00142	CcSEcCtD
Agomelatine—Vomiting—Dorzolamide—glaucoma	0.000573	0.00141	CcSEcCtD
Agomelatine—Hyperhidrosis—Betaxolol—glaucoma	0.000572	0.00141	CcSEcCtD
Agomelatine—Headache—Dorzolamide—glaucoma	0.000564	0.00139	CcSEcCtD
Agomelatine—Vomiting—Brinzolamide—glaucoma	0.000563	0.00139	CcSEcCtD
Agomelatine—Dizziness—Pilocarpine—glaucoma	0.000563	0.00139	CcSEcCtD
Agomelatine—Headache—Travoprost—glaucoma	0.000562	0.00139	CcSEcCtD
Agomelatine—Nausea—Brimonidine—glaucoma	0.00056	0.00138	CcSEcCtD
Agomelatine—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000558	0.00351	CbGpPWpGaD
Agomelatine—Vision blurred—Timolol—glaucoma	0.000558	0.00138	CcSEcCtD
Agomelatine—Gastrointestinal pain—Clonidine—glaucoma	0.000556	0.00137	CcSEcCtD
Agomelatine—Headache—Brinzolamide—glaucoma	0.000555	0.00137	CcSEcCtD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000542	0.00341	CbGpPWpGaD
Agomelatine—Angioedema—Timolol—glaucoma	0.000541	0.00134	CcSEcCtD
Agomelatine—Vomiting—Pilocarpine—glaucoma	0.000541	0.00134	CcSEcCtD
Agomelatine—Urticaria—Clonidine—glaucoma	0.00054	0.00133	CcSEcCtD
Agomelatine—Abdominal pain—Clonidine—glaucoma	0.000537	0.00133	CcSEcCtD
Agomelatine—Insomnia—Betaxolol—glaucoma	0.000535	0.00132	CcSEcCtD
Agomelatine—Nausea—Dorzolamide—glaucoma	0.000535	0.00132	CcSEcCtD
Agomelatine—Headache—Pilocarpine—glaucoma	0.000533	0.00132	CcSEcCtD
Agomelatine—Nausea—Travoprost—glaucoma	0.000533	0.00131	CcSEcCtD
Agomelatine—Vertigo—Timolol—glaucoma	0.000532	0.00131	CcSEcCtD
Agomelatine—Paraesthesia—Betaxolol—glaucoma	0.000531	0.00131	CcSEcCtD
Agomelatine—Nausea—Brinzolamide—glaucoma	0.000526	0.0013	CcSEcCtD
Agomelatine—Dyspepsia—Betaxolol—glaucoma	0.000521	0.00129	CcSEcCtD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000518	0.00325	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000518	0.00325	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000516	0.00324	CbGpPWpGaD
Agomelatine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000511	0.00126	CcSEcCtD
Agomelatine—Fatigue—Betaxolol—glaucoma	0.00051	0.00126	CcSEcCtD
Agomelatine—Constipation—Betaxolol—glaucoma	0.000506	0.00125	CcSEcCtD
Agomelatine—Nausea—Pilocarpine—glaucoma	0.000506	0.00125	CcSEcCtD
Agomelatine—Anxiety—Timolol—glaucoma	0.000503	0.00124	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000501	0.00124	CcSEcCtD
Agomelatine—Dry mouth—Timolol—glaucoma	0.000493	0.00122	CcSEcCtD
Agomelatine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000492	0.00309	CbGpPWpGaD
Agomelatine—Asthenia—Clonidine—glaucoma	0.000488	0.0012	CcSEcCtD
Agomelatine—HTR2B—GPCR ligand binding—OPN4—glaucoma	0.000487	0.00306	CbGpPWpGaD
Agomelatine—Pruritus—Clonidine—glaucoma	0.000481	0.00119	CcSEcCtD
Agomelatine—Infection—Timolol—glaucoma	0.00048	0.00119	CcSEcCtD
Agomelatine—Nervous system disorder—Timolol—glaucoma	0.000474	0.00117	CcSEcCtD
Agomelatine—Urticaria—Betaxolol—glaucoma	0.00047	0.00116	CcSEcCtD
Agomelatine—Skin disorder—Timolol—glaucoma	0.00047	0.00116	CcSEcCtD
Agomelatine—Hyperhidrosis—Timolol—glaucoma	0.000467	0.00115	CcSEcCtD
Agomelatine—Diarrhoea—Clonidine—glaucoma	0.000465	0.00115	CcSEcCtD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000464	0.00292	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—OPN4—glaucoma	0.000457	0.00287	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—OPN4—glaucoma	0.000457	0.00287	CbGpPWpGaD
Agomelatine—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000452	0.00284	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—EDN1—glaucoma	0.000451	0.00284	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—EDN1—glaucoma	0.000451	0.00284	CbGpPWpGaD
Agomelatine—Dizziness—Clonidine—glaucoma	0.000449	0.00111	CcSEcCtD
Agomelatine—HTR2B—GPCR ligand binding—PTGFR—glaucoma	0.000438	0.00275	CbGpPWpGaD
Agomelatine—Insomnia—Timolol—glaucoma	0.000437	0.00108	CcSEcCtD
Agomelatine—Paraesthesia—Timolol—glaucoma	0.000434	0.00107	CcSEcCtD
Agomelatine—Vomiting—Clonidine—glaucoma	0.000432	0.00107	CcSEcCtD
Agomelatine—Somnolence—Timolol—glaucoma	0.00043	0.00106	CcSEcCtD
Agomelatine—Headache—Clonidine—glaucoma	0.000426	0.00105	CcSEcCtD
Agomelatine—Dyspepsia—Timolol—glaucoma	0.000426	0.00105	CcSEcCtD
Agomelatine—MTNR1A—Signaling Pathways—HEYL—glaucoma	0.000425	0.00267	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HEYL—glaucoma	0.000425	0.00267	CbGpPWpGaD
Agomelatine—Asthenia—Betaxolol—glaucoma	0.000425	0.00105	CcSEcCtD
Agomelatine—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000423	0.00265	CbGpPWpGaD
Agomelatine—Pruritus—Betaxolol—glaucoma	0.000419	0.00103	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Timolol—glaucoma	0.000417	0.00103	CcSEcCtD
Agomelatine—Fatigue—Timolol—glaucoma	0.000417	0.00103	CcSEcCtD
Agomelatine—MTNR1B—Signaling Pathways—PTGFR—glaucoma	0.000412	0.00259	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—PTGFR—glaucoma	0.000412	0.00259	CbGpPWpGaD
Agomelatine—Diarrhoea—Betaxolol—glaucoma	0.000405	0.000999	CcSEcCtD
Agomelatine—Nausea—Clonidine—glaucoma	0.000404	0.000996	CcSEcCtD
Agomelatine—Gastrointestinal pain—Timolol—glaucoma	0.000395	0.000975	CcSEcCtD
Agomelatine—MTNR1A—GPCR ligand binding—C3—glaucoma	0.000394	0.00248	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—C3—glaucoma	0.000394	0.00248	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—OPN4—glaucoma	0.000393	0.00247	CbGpPWpGaD
Agomelatine—Dizziness—Betaxolol—glaucoma	0.000391	0.000966	CcSEcCtD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000386	0.00243	CbGpPWpGaD
Agomelatine—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000386	0.00243	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000386	0.00243	CbGpPWpGaD
Agomelatine—Urticaria—Timolol—glaucoma	0.000384	0.000948	CcSEcCtD
Agomelatine—Abdominal pain—Timolol—glaucoma	0.000382	0.000943	CcSEcCtD
Agomelatine—Vomiting—Betaxolol—glaucoma	0.000376	0.000928	CcSEcCtD
Agomelatine—Headache—Betaxolol—glaucoma	0.000371	0.000915	CcSEcCtD
Agomelatine—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000367	0.00231	CbGpPWpGaD
Agomelatine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000365	0.00229	CbGpPWpGaD
Agomelatine—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000361	0.00227	CbGpPWpGaD
Agomelatine—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00036	0.00226	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—PTGFR—glaucoma	0.000354	0.00222	CbGpPWpGaD
Agomelatine—Nausea—Betaxolol—glaucoma	0.000352	0.000867	CcSEcCtD
Agomelatine—MTNR1B—Signaling by GPCR—SMO—glaucoma	0.000351	0.00221	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—SMO—glaucoma	0.000351	0.00221	CbGpPWpGaD
Agomelatine—Asthenia—Timolol—glaucoma	0.000347	0.000856	CcSEcCtD
Agomelatine—Pruritus—Timolol—glaucoma	0.000342	0.000844	CcSEcCtD
Agomelatine—Diarrhoea—Timolol—glaucoma	0.000331	0.000816	CcSEcCtD
Agomelatine—MTNR1B—Signaling Pathways—RPTOR—glaucoma	0.000322	0.00202	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—RPTOR—glaucoma	0.000322	0.00202	CbGpPWpGaD
Agomelatine—Dizziness—Timolol—glaucoma	0.00032	0.000789	CcSEcCtD
Agomelatine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000312	0.00196	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NCK2—glaucoma	0.000312	0.00196	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NCK2—glaucoma	0.000312	0.00196	CbGpPWpGaD
Agomelatine—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000308	0.00194	CbGpPWpGaD
Agomelatine—Vomiting—Timolol—glaucoma	0.000307	0.000758	CcSEcCtD
Agomelatine—Headache—Timolol—glaucoma	0.000303	0.000747	CcSEcCtD
Agomelatine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000296	0.00186	CbGpPWpGaD
Agomelatine—HTR2B—G alpha (q) signalling events—EDN1—glaucoma	0.000289	0.00182	CbGpPWpGaD
Agomelatine—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000288	0.00181	CbGpPWpGaD
Agomelatine—Nausea—Timolol—glaucoma	0.000287	0.000709	CcSEcCtD
Agomelatine—MTNR1A—Circadian rythm related genes—TP53—glaucoma	0.00028	0.00176	CbGpPWpGaD
Agomelatine—MTNR1B—Circadian rythm related genes—TP53—glaucoma	0.00028	0.00176	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—OPN4—glaucoma	0.000275	0.00173	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HDAC9—glaucoma	0.000265	0.00167	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HDAC9—glaucoma	0.000265	0.00167	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000258	0.00162	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—EDN1—glaucoma	0.000255	0.0016	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—EDN1—glaucoma	0.000255	0.0016	CbGpPWpGaD
Agomelatine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000253	0.00159	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—OPN4—glaucoma	0.00025	0.00157	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PTGFR—glaucoma	0.000248	0.00156	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—EDN1—glaucoma	0.000233	0.00146	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—EDN1—glaucoma	0.000232	0.00146	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—EDN1—glaucoma	0.000232	0.00146	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PTGFR—glaucoma	0.000225	0.00141	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—C3—glaucoma	0.000223	0.0014	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—C3—glaucoma	0.000223	0.0014	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—OPN4—glaucoma	0.000222	0.00139	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—SMO—glaucoma	0.000221	0.00139	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—LRP12—glaucoma	0.000213	0.00134	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000209	0.00131	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—SMO—glaucoma	0.000208	0.0013	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—SMO—glaucoma	0.000208	0.0013	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—C3—glaucoma	0.000202	0.00127	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—C3—glaucoma	0.000202	0.00127	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—OPN4—glaucoma	0.000202	0.00127	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PTGFR—glaucoma	0.0002	0.00126	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—GSTT1—glaucoma	0.000197	0.00124	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000191	0.0012	CbGpPWpGaD
Agomelatine—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	0.00019	0.0012	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NTRK2—glaucoma	0.00019	0.00119	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NTRK2—glaucoma	0.00019	0.00119	CbGpPWpGaD
Agomelatine—CYP1A2—Phase II conjugation—GSTM1—glaucoma	0.000184	0.00115	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PTGFR—glaucoma	0.000181	0.00114	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—SMO—glaucoma	0.000178	0.00112	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000174	0.00109	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LRP12—glaucoma	0.000172	0.00108	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—GSTT1—glaucoma	0.000169	0.00106	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000167	0.00105	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000165	0.00104	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000165	0.00104	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NGFR—glaucoma	0.000163	0.00102	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NGFR—glaucoma	0.000163	0.00102	CbGpPWpGaD
Agomelatine—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	0.000163	0.00102	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—CYP1B1—glaucoma	0.000157	0.000988	CbGpPWpGaD
Agomelatine—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	0.000155	0.000975	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NTRK1—glaucoma	0.000155	0.000972	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NTRK1—glaucoma	0.000155	0.000972	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000154	0.00097	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—OPN4—glaucoma	0.000148	0.000927	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000147	0.000923	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—EDN1—glaucoma	0.000146	0.000916	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CDKN2B—glaucoma	0.000143	0.000896	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CDKN2B—glaucoma	0.000143	0.000896	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CA5A—glaucoma	0.000138	0.000869	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NARFL—glaucoma	0.000138	0.000869	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HEYL—glaucoma	0.000137	0.000862	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000137	0.000861	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—EDN1—glaucoma	0.000137	0.00086	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—EDN1—glaucoma	0.000137	0.00086	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000135	0.000847	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—CYP1B1—glaucoma	0.000134	0.000844	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PTGFR—glaucoma	0.000133	0.000835	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	0.000133	0.000833	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—C3—glaucoma	0.000127	0.0008	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NGF—glaucoma	0.000126	0.00079	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NGF—glaucoma	0.000126	0.00079	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—GSTM1—glaucoma	0.000126	0.00079	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000126	0.000789	CbGpPWpGaD
Agomelatine—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	0.000124	0.000779	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—C3—glaucoma	0.00012	0.000751	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—C3—glaucoma	0.00012	0.000751	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—OPN4—glaucoma	0.000119	0.000748	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NARFL—glaucoma	0.000118	0.000743	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CA5A—glaucoma	0.000118	0.000743	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—EDN1—glaucoma	0.000118	0.000739	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000117	0.000738	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000117	0.000738	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—SMO—glaucoma	0.000113	0.000713	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—APOE—glaucoma	0.000111	0.000699	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—APOE—glaucoma	0.000111	0.000699	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HEYL—glaucoma	0.000111	0.000695	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CAV1—glaucoma	0.00011	0.000693	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CAV1—glaucoma	0.00011	0.000693	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—GSTM1—glaucoma	0.000107	0.000675	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PTGFR—glaucoma	0.000107	0.000674	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	0.000106	0.000666	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—FN1—glaucoma	0.000105	0.000659	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—FN1—glaucoma	0.000105	0.000659	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RPTOR—glaucoma	0.000104	0.000653	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—BAD—glaucoma	0.000104	0.000652	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—BAD—glaucoma	0.000104	0.000652	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—C3—glaucoma	0.000103	0.000645	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NCK2—glaucoma	0.000101	0.000633	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—SMO—glaucoma	9.15e-05	0.000575	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HDAC9—glaucoma	8.56e-05	0.000538	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RPTOR—glaucoma	8.39e-05	0.000527	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NOS3—glaucoma	8.34e-05	0.000524	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NOS3—glaucoma	8.34e-05	0.000524	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—EDN1—glaucoma	8.24e-05	0.000517	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NCK2—glaucoma	8.13e-05	0.00051	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—EDN1—glaucoma	7.48e-05	0.00047	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CDKN1B—glaucoma	7.22e-05	0.000454	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CDKN1B—glaucoma	7.22e-05	0.000454	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—C3—glaucoma	7.19e-05	0.000452	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HDAC9—glaucoma	6.91e-05	0.000434	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CA1—glaucoma	6.76e-05	0.000424	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SMO—glaucoma	6.7e-05	0.000421	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MMP9—glaucoma	6.69e-05	0.00042	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MMP9—glaucoma	6.69e-05	0.00042	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—EDN1—glaucoma	6.64e-05	0.000417	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CTSA—glaucoma	6.54e-05	0.000411	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—C3—glaucoma	6.53e-05	0.00041	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CA2—glaucoma	6.18e-05	0.000388	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NTRK2—glaucoma	6.13e-05	0.000385	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.04e-05	0.000379	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.04e-05	0.000379	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—EDN1—glaucoma	6.03e-05	0.000379	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—VEGFA—glaucoma	6.01e-05	0.000377	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—VEGFA—glaucoma	6.01e-05	0.000377	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—C3—glaucoma	5.8e-05	0.000365	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CA1—glaucoma	5.77e-05	0.000363	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CTSA—glaucoma	5.59e-05	0.000351	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SMO—glaucoma	5.41e-05	0.00034	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CA2—glaucoma	5.28e-05	0.000332	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—C3—glaucoma	5.27e-05	0.000331	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NGFR—glaucoma	5.26e-05	0.00033	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.16e-05	0.000324	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.16e-05	0.000324	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NTRK1—glaucoma	5e-05	0.000314	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NTRK2—glaucoma	4.94e-05	0.000311	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CDKN2B—glaucoma	4.6e-05	0.000289	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TP53—glaucoma	4.54e-05	0.000285	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TP53—glaucoma	4.54e-05	0.000285	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EDN1—glaucoma	4.42e-05	0.000278	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TXN—glaucoma	4.35e-05	0.000274	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NGFR—glaucoma	4.24e-05	0.000267	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NGF—glaucoma	4.06e-05	0.000255	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NTRK1—glaucoma	4.03e-05	0.000253	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.97e-05	0.00025	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.94e-05	0.000247	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—C3—glaucoma	3.86e-05	0.000242	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TXN—glaucoma	3.72e-05	0.000234	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CDKN2B—glaucoma	3.71e-05	0.000233	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOE—glaucoma	3.59e-05	0.000226	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EDN1—glaucoma	3.56e-05	0.000224	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CAV1—glaucoma	3.56e-05	0.000224	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.39e-05	0.000213	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FN1—glaucoma	3.39e-05	0.000213	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTT1—glaucoma	3.38e-05	0.000212	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.36e-05	0.000211	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—BAD—glaucoma	3.35e-05	0.00021	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NGF—glaucoma	3.28e-05	0.000206	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—C3—glaucoma	3.11e-05	0.000196	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOE—glaucoma	2.9e-05	0.000182	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTT1—glaucoma	2.88e-05	0.000181	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CAV1—glaucoma	2.87e-05	0.00018	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FN1—glaucoma	2.73e-05	0.000172	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.72e-05	0.000171	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—BAD—glaucoma	2.7e-05	0.00017	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOS3—glaucoma	2.69e-05	0.000169	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ABCA1—glaucoma	2.69e-05	0.000169	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP1B1—glaucoma	2.69e-05	0.000169	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CDKN1B—glaucoma	2.33e-05	0.000146	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.33e-05	0.000146	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP1B1—glaucoma	2.3e-05	0.000144	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ABCA1—glaucoma	2.3e-05	0.000144	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOS3—glaucoma	2.17e-05	0.000136	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MMP9—glaucoma	2.16e-05	0.000136	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTM1—glaucoma	2.15e-05	0.000135	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—VEGFA—glaucoma	1.94e-05	0.000122	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MTHFR—glaucoma	1.9e-05	0.000119	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CDKN1B—glaucoma	1.88e-05	0.000118	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTM1—glaucoma	1.84e-05	0.000115	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOE—glaucoma	1.77e-05	0.000111	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CAV1—glaucoma	1.75e-05	0.00011	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MMP9—glaucoma	1.74e-05	0.000109	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MTHFR—glaucoma	1.62e-05	0.000102	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—VEGFA—glaucoma	1.56e-05	9.83e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOE—glaucoma	1.51e-05	9.5e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CAV1—glaucoma	1.5e-05	9.41e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TP53—glaucoma	1.47e-05	9.21e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NOS3—glaucoma	1.33e-05	8.33e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PTGS2—glaucoma	1.21e-05	7.62e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TP53—glaucoma	1.18e-05	7.43e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NOS3—glaucoma	1.13e-05	7.12e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PTGS2—glaucoma	1.04e-05	6.51e-05	CbGpPWpGaD
